Transition from Clinical Trials to RWE in Psoriatic Arthritis & Plaque Psoriasis

المقدمة
سجل الان

From Clinical Trials to RWE in PsA & PsO

الأهداف

•Present current scientific evidence, including clinical trials, Real-world data, and illustrative case studies, on the management of PsA & PsO
•Communicate Ixekizumab and Baricitinib value proposition to highlight what the product may mean to people living with Psoriatic Arthritis (PsA)& Plaque Psoriasis (PsO) respectively.

المستهدفين :

Physician ( Dermatology , Rheumatology )

Resident / Fellow ( Dermatology , Rheumatology )

المتحدثين

Dr Ahmed Ismail

Consultant & Head of Dermatology Dept.
Dr. Erfan & Bagedo General Hospital – Jeddah.
Lecturer of Dermatology & Venerology
Al Azhar Faculty of Medicine